E09.621 Drug or chemical induced diabetes mellitus with foot ulcer

Name of the Condition

• Drug or Chemical Induced Diabetes Mellitus with Foot Ulcer (ICD-10 Code: E09.621)

Summary

Drug or chemical induced diabetes mellitus with foot ulcer is a condition where elevated blood sugar levels, caused by exposure to specific medications or chemicals, lead to foot ulceration. This form of diabetes is directly attributable to external factors that disrupt glucose metabolism, resulting in hyperglycemia and associated foot complications.

Causes

The condition is caused by exposure to drugs or chemicals that impair glucose regulation, leading to uncontrolled hyperglycemia and subsequent foot ulceration. Common culprits include medications (e.g., glucocorticoids, antipsychotics, or diuretics) and toxins that reduce insulin secretion or increase insulin resistance. These substances trigger hyperglycemia, which, if untreated, progresses to foot ulcers due to metabolic changes affecting tissue integrity and healing.

Risk Factors

• Use of medications known to affect glucose metabolism (e.g., steroids, antiretrovirals).
• Exposure to chemicals or toxins that disrupt endocrine function.
• Pre-existing metabolic conditions that increase susceptibility to drug-induced effects.
• Dosage and duration of exposure to the causative agent.
• Inadequate management of hyperglycemia.
• Peripheral neuropathy or vascular disease.

Symptoms

• Foot pain or numbness.
• Non-healing sores or ulcers on the feet.
• Swelling or redness around the affected area.
• Discharge or odor from the ulcer.
• Changes in skin color or temperature.

Diagnosis

Diagnosis involves confirming hyperglycemia linked to drug or chemical exposure and identifying a foot ulcer. Clinical evaluation includes assessing the ulcer’s characteristics, underlying tissue damage, and vascular or neurological status. Laboratory tests may measure blood glucose levels, while imaging or wound cultures help evaluate severity and infection. Documentation must link the ulcer to the induced diabetes and exclude other causes.

Treatment Options

Treatment focuses on managing hyperglycemia, promoting ulcer healing, and addressing infection. This may include discontinuing or adjusting the causative agent, glycemic control (e.g., insulin or oral hypoglycemics), wound care (debridement, dressings), and antibiotics for infected ulcers. Offloading pressure, vascular assessment, and referral to specialists (e.g., podiatry) are often necessary.

Prognosis and Follow-Up

Prognosis depends on timely intervention, glycemic control, and ulcer severity. Early treatment improves healing, while delayed care increases risks of infection or amputation. Follow-up includes regular wound assessments, glycemic monitoring, and preventive measures (e.g., foot care education) to avoid recurrence.

Complications

• Infection (cellulitis, osteomyelitis).
• Gangrene or tissue necrosis.
• Amputation.
• Delayed healing or chronic ulcers.
• Spread of infection to deeper tissues.

Lifestyle & Prevention

• Monitor blood glucose levels closely.
• Inspect feet daily for sores or changes.
• Wear proper footwear to reduce pressure.
• Maintain good foot hygiene.
• Avoid smoking, which impairs circulation.
• Follow prescribed medication regimens and report adverse effects.

When to Seek Professional Help

Seek care if foot ulcers appear, worsen, or show signs of infection (e.g., increased pain, redness, discharge). Prompt evaluation is critical to prevent complications, especially if hyperglycemia is uncontrolled or the ulcer does not heal.

Tips for Medical Coders

Document the causative drug or chemical, the link between exposure and hyperglycemia, and the foot ulcer’s characteristics (e.g., location, severity). Ensure the ulcer is clearly attributed to the induced diabetes, with supporting clinical details. Code E09.621 is specific to foot ulcers; verify no other complications are present that would require a different code.